ATXN7 抗体 (Middle Region)
Quick Overview for ATXN7 抗体 (Middle Region) (ABIN927440)
抗原
See all ATXN7 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- Middle Region
-
交叉反应
- 大鼠, 小鼠, 犬, 小鸡
-
纯化方法
- Purified
-
免疫原
- ATXN7 antibody was raised in rabbit using the middle region of ATXN7 as the immunogen
-
-
-
-
应用备注
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
ATXN7 Blocking Peptide, (ABIN5612243), is also available for use as a blocking control in assays to test for specificity of this ATXN7 antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- Lot specific
-
缓冲液
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ATXN7 (Ataxin 7 (ATXN7))
-
别名
- ATXN7
-
背景
- ATXN7 is involved in neurodegeneration. ATXN7 acts as component of the STAGA transcription coactivator-HAT complex. ATXN7 mediates the interaction of STAGA complex with the CRX and is involved in CRX-dependent gene activation.The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Synonyms: Polyclonal ATXN7 antibody, Anti-ATXN7 antibody, ataxin 7 antibody, ADCAII antibody, OPCA3 antibody, SCA7 antibody.
抗原
-